| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (NCT00004241) | National Cancer Institute (NCI) | 1999-10-01 |
| Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT00004862) | National Cancer Institute (NCI) | 1999-10-01 |
| Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00004242) | National Cancer Institute (NCI) | 1999-10-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00019994) | National Cancer Institute (NCI) | 1999-10-01 |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura (NCT00019825) | National Cancer Institute (NCI) | 1999-10-01 |
| Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma (NCT00004148) | National Cancer Institute (NCI) | 1999-10-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00019669) | National Cancer Institute (NCI) | 1999-10-01 |
| Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer (NCT00004189) | National Cancer Institute (NCI) | 1999-10-01 |
| Endostatin in Treating Patients With Advanced Solid Tumors (NCT00004229) | National Cancer Institute (NCI) | 1999-10-01 |
| Oxaliplatin in Cancer Patients With Impaired Kidney Function (NCT00001835) | National Cancer Institute (NCI) | 1999-09-01 |
| Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics (NCT00341458) | National Cancer Institute (NCI) | 1999-09-01 |
| Effects of Raloxifene on Hormone Levels (NCT00026962) | National Cancer Institute (NCI) | 1999-09-01 |
| Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 (NCT00003995) | National Cancer Institute (NCI) | 1999-09-01 |
| 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma (NCT00003837) | National Cancer Institute (NCI) | 1999-09-01 |
| Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers (NCT02099136) | National Cancer Institute (NCI) | 1999-09-01 |
| Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma (NCT00001832) | National Cancer Institute (NCI) | 1999-08-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer (NCT00004089) | National Cancer Institute (NCI) | 1999-08-01 |
| Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 (NCT00003992) | National Cancer Institute (NCI) | 1999-08-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer (NCT00004097) | National Cancer Institute (NCI) | 1999-08-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx (NCT00004094) | National Cancer Institute (NCI) | 1999-08-01 |
| Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00004079) | National Cancer Institute (NCI) | 1999-08-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Study of Etoposide in Breast Cancer Patients (NCT00026949) | National Cancer Institute (NCI) | 1999-08-01 |
| Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma (NCT00003909) | National Cancer Institute (NCI) | 1999-08-01 |
| Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer (NCT00019656) | National Cancer Institute (NCI) | 1999-08-01 |
| p53 Vaccine for Ovarian Cancer (NCT00001827) | National Cancer Institute (NCI) | 1999-07-26 |
| Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants (NCT00001830) | National Cancer Institute (NCI) | 1999-07-20 |
| Evaluation for NCI Surgery Branch Clinical Research Protocols (NCT00001823) | National Cancer Institute (NCI) | 1999-07-11 |
| UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia (NCT00019838) | National Cancer Institute (NCI) | 1999-07-01 |
| Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors (NCT00019630) | National Cancer Institute (NCI) | 1999-07-01 |
| ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer (NCT00006106) | National Cancer Institute (NCI) | 1999-07-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00019734) | National Cancer Institute (NCI) | 1999-07-01 |
| Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer (NCT00019773) | National Cancer Institute (NCI) | 1999-07-01 |
| Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer (NCT00003832) | National Cancer Institute (NCI) | 1999-07-01 |
| Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor (NCT00001826) | National Cancer Institute (NCI) | 1999-07-01 |
| 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia (NCT00003997) | National Cancer Institute (NCI) | 1999-07-01 |
| Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation (NCT00342966) | National Cancer Institute (NCI) | 1999-06-14 |
| Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer (NCT00003968) | National Cancer Institute (NCI) | 1999-06-01 |
| Combination Drug Treatment of Pediatric HIV Infection (NCT00001818) | National Cancer Institute (NCI) | 1999-06-01 |
| Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia (NCT00003620) | National Cancer Institute (NCI) | 1999-06-01 |
| Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00019708) | National Cancer Institute (NCI) | 1999-06-01 |
| Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia (NCT00003934) | National Cancer Institute (NCI) | 1999-06-01 |
| Nutrition Intervention Trials in Linxian Follow-up Study (NCT00342654) | National Cancer Institute (NCI) | 1999-05-20 |
| Costa Rican Natural History Study of HPV and Cervical Neoplasia (NCT00342173) | National Cancer Institute (NCI) | 1999-05-20 |
| Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy (NCT00001813) | National Cancer Institute (NCI) | 1999-05-10 |
| Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study (NCT00342433) | National Cancer Institute (NCI) | 1999-05-05 |
| O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors (NCT00003765) | National Cancer Institute (NCI) | 1999-05-01 |
| A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning (NCT00026936) | National Cancer Institute (NCI) | 1999-05-01 |
| The Impact of Starbright World on Children Being Treated at the NIH (NCT00001816) | National Cancer Institute (NCI) | 1999-05-01 |
| Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer (NCT00003799) | National Cancer Institute (NCI) | 1999-05-01 |
| Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas (NCT00003745) | National Cancer Institute (NCI) | 1999-05-01 |
| Combination Chemotherapy in Treating Patients With Stage III Colon Cancer (NCT00003835) | National Cancer Institute (NCI) | 1999-05-01 |
| Irofulven in Treating Patients With Metastatic Breast Cancer (NCT00003796) | National Cancer Institute (NCI) | 1999-05-01 |
| (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy (NCT00001807) | National Cancer Institute (NCI) | 1999-04-16 |
| Methods in Education for Breast Cancer Genetics (NCT00001806) | National Cancer Institute (NCI) | 1999-04-06 |
| Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer (NCT00003873) | National Cancer Institute (NCI) | 1999-04-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00019721) | National Cancer Institute (NCI) | 1999-04-01 |
| Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer (NCT00003869) | National Cancer Institute (NCI) | 1999-04-01 |
| Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma (NCT00003778) | National Cancer Institute (NCI) | 1999-04-01 |
| Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00003850) | National Cancer Institute (NCI) | 1999-04-01 |
| A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 (NCT00001812) | National Cancer Institute (NCI) | 1999-04-01 |
| O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma (NCT00003613) | National Cancer Institute (NCI) | 1999-04-01 |
| Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma (NCT00003895) | National Cancer Institute (NCI) | 1999-04-01 |
| 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis (NCT00003853) | National Cancer Institute (NCI) | 1999-04-01 |
| Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples (NCT00001814) | National Cancer Institute (NCI) | 1999-04-01 |
| An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections (NCT00001810) | National Cancer Institute (NCI) | 1999-04-01 |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma (NCT00003665) | National Cancer Institute (NCI) | 1999-04-01 |
| A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab (NCT00001805) | National Cancer Institute (NCI) | 1999-03-01 |
| Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg (NCT00003789) | National Cancer Institute (NCI) | 1999-03-01 |
| Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer (NCT00019695) | National Cancer Institute (NCI) | 1999-03-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer (NCT00019591) | National Cancer Institute (NCI) | 1999-03-01 |
| Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase (NCT00003694) | National Cancer Institute (NCI) | 1999-03-01 |
| Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma (NCT00003350) | National Cancer Institute (NCI) | 1999-03-01 |
| Von Hippel-Lindau Disease Genetic Epidemiology Study (NCT00001803) | National Cancer Institute (NCI) | 1999-02-26 |
| Physicians Survey on Genetic Testing (NCT00341107) | National Cancer Institute (NCI) | 1999-02-01 |
| Eflornithine in Treating Patients With Bladder Cancer (NCT00003814) | National Cancer Institute (NCI) | 1999-02-01 |
| Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families (NCT00341627) | National Cancer Institute (NCI) | 1999-02-01 |
| Extended Follow-up of Columbia, MO Serum Bank Participants (NCT00340210) | National Cancer Institute (NCI) | 1999-01-14 |
| A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners (NCT00342264) | National Cancer Institute (NCI) | 1999-01-12 |
| Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer (NCT00004038) | National Cancer Institute (NCI) | 1999-01-01 |
| Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma (NCT00003970) | National Cancer Institute (NCI) | 1999-01-01 |
| A Phase II Evaluation of Telesurgery Systems (NCT00026923) | National Cancer Institute (NCI) | 1999-01-01 |
| Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma (NCT00003595) | National Cancer Institute (NCI) | 1999-01-01 |
| Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia (NCT00330382) | National Cancer Institute (NCI) | 1999-01-01 |
| Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis (NCT00001797) | National Cancer Institute (NCI) | 1999-01-01 |
| Vaccine Therapy in Treating Patients With Melanoma (NCT00003556) | National Cancer Institute (NCI) | 1999-01-01 |
| Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma (NCT00003575) | National Cancer Institute (NCI) | 1999-01-01 |
| Raloxifene in Preventing Breast Cancer in Premenopausal Women (NCT00019500) | National Cancer Institute (NCI) | 1998-12-01 |
| Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia (NCT00021983) | National Cancer Institute (NCI) | 1998-12-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer (NCT00019539) | National Cancer Institute (NCI) | 1998-11-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00019487) | National Cancer Institute (NCI) | 1998-11-01 |
| Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia (NCT00001790) | National Cancer Institute (NCI) | 1998-10-01 |
| Interdisciplinary Case-Control Study of Bladder Cancer in Spain (NCT00341861) | National Cancer Institute (NCI) | 1998-09-01 |
| Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00019552) | National Cancer Institute (NCI) | 1998-09-01 |
| Raltitrexed in Treating Children With Refractory Acute Leukemia (NCT00003528) | National Cancer Institute (NCI) | 1998-09-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00019448) | National Cancer Institute (NCI) | 1998-09-01 |
| Gene Therapy in Treating Patients With Ovarian Cancer (NCT00003588) | National Cancer Institute (NCI) | 1998-09-01 |
| Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer (NCT00003439) | National Cancer Institute (NCI) | 1998-08-01 |
| Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma (NCT00001703) | National Cancer Institute (NCI) | 1998-08-01 |
| 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT00003545) | National Cancer Institute (NCI) | 1998-08-01 |